Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10201/17906

Título: Neuron specific enolase-positive breast carcinomas
Fecha de publicación: 1988
Editorial: Murcia : F. Hernández
ISSN: 0213-3911
Materias relacionadas: CDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología
Palabras clave: Breast carcinoma
Immunocytochemistry
Resumen: Ninety-eight patients treated for breast carcinomas were followed from 54 to 75 months after primary diagnosis. All had undergone a modified radical mastectomy with removal of axillary lymph nodes. 36 breast carcinomas were NSE-positive and 62 were negative. NSE-positive tumours were significantly more frequently estrogen receptor-positive than the NSEnegative tumours, and the estrogen receptor values were higher in the NSE-positive groups. Patients with NSE-positive tumours and patients with NSE-negative tumours did not differ with regard to presence of lymph node metastases at the time of primary surgery. However, the study showed that patients with NSE-positive tumours had a tendency towards more lymph node metastases after primary surgical intervention, but a better outcome than patients with NSE-negative tumours and metastases. This study, with a 5-year follow up, failed to demonstrate any major prognostic significance of immunostaining for NSE.
Autor/es principal/es: Erikstein, Bjerrn
Nesland, Jahn M.
Ottestad, Lars
Lund, Eiliv
Johannessen, Jan Vicents
Publicado en: Histology and histopathology
URI: http://hdl.handle.net/10201/17906
Tipo de documento: info:eu-repo/semantics/article
Número páginas / Extensión: 6
Derechos: info:eu-repo/semantics/openAccess
Aparece en las colecciones:Vol. 3, nº 1 (1988)

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
Neuron specific enolasepositive breast carcinomas.pdf350,53 kBAdobe PDFVista previa
Visualizar/Abrir


Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.